Meanwhile, knocking down IDO1 in Rapa-SLE-EVs partially reversed the inhibitory effects on SLE-B cells, especially significantly affecting the suppression of antibody secretion. This evidence concerns the gene TRERF1 and systemic lupus erythematosus.